Stockreport

IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Chairman Allegedly Misbranded Cancer Drug: Levi & Korsinsky

ImmunityBio, Inc.  (IBRX) 
PDF Notice to Pension Funds, Asset Managers, and Fiduciaries NEW YORK--(BUSINESS WIRE)-- Institutional investors holding positions in ImmunityBio, Inc. (NASDAQ: IBRX) dur [Read more]